Baidu
map

西安交大一附西北地区率先实施左心耳与房间隔缺损联合封堵手术

2015-06-15 缑永强 李晨皎 医学论坛网

西安交大一附院心血管病医院张玉顺教授团队近日成功完成一例心房颤动合并房间隔缺损患者的左心耳与房间隔缺损联合封堵手术。目前患者已康复出院。该患者有多年房颤病史,同时合并高龄女性、高血压病、短暂性脑缺血发作、肝功能异常等多重危险因素,近期病情加重,危及生命。在充分权衡患者血栓栓塞风险与服用抗凝药物的出血风险后,张玉顺教授与患者及家属充分交流后决定实施左心耳封堵手术,降低栓塞风险的同时也避免出血风险增加

西安交大一附院心血管病医院张玉顺教授团队近日成功完成一例心房颤动合并房间隔缺损患者的左心耳与房间隔缺损联合封堵手术。目前患者已康复出院。

该患者有多年房颤病史,同时合并高龄女性、高血压病、短暂性脑缺血发作、肝功能异常等多重危险因素,近期病情加重,危及生命。在充分权衡患者血栓栓塞风险与服用抗凝药物的出血风险后,张玉顺教授与患者及家属充分交流后决定实施左心耳封堵手术,降低栓塞风险的同时也避免出血风险增加。由于患者还合并先天性房间隔缺损,是否联合行房间隔缺损封堵术亦增加手术难度。在麻醉科、手术室等科室大力配合下,医术精湛的张玉顺教授团队历时半小时,圆满完成左心耳与房间隔缺损联合封堵手术,为该患者解除了病痛,降低心脑血管栓塞风险。

房颤患者中风风险是普通人的五倍,而由房颤引起的中风通常更严重,致死、致残率更高,也更容易复发。在非瓣膜性房颤中,90%以上血栓的形成与左心耳有关。目前治疗房颤引起的血栓栓塞性疾病的常规治疗方法是服用抗凝药,服药过程漫长而且作用局限,无论是华法令还是新型抗凝药,大约21-28%的患者会因药物不良反应出血等并发症而停药。经皮左心耳封堵术是近年来发展起来的一种预防房颤患者血栓栓塞事件的创新治疗术式。通过导管将一左心耳封堵器安置在左心耳开口部位,达到封闭左心耳,封预防左心耳内血栓脱落引起的血栓栓塞,从而避免缺血性脑卒中和全身性栓塞的发生。由于其采用微创技术,术后当日患者即可起床活动,手术并发症少,而且手术时间较短,对于老年人或者不能耐受外科手术的患者来说也很安全。左心耳封堵术能消除患者对于长期抗凝治疗的依赖,避免了患者因抗凝药物所产生的不耐受、出血事件和依从性等问题,也为对抗凝药物具有禁忌证的患者带来了新希望。

自从2014年底西安交大一附院心血管病医院张玉顺教授团队完成了西北首例左心耳封堵术,学科认真开展此项工作,患者的随访规范进行。此次手术的成功完成得益于院方及医务部等多部门的有力支持帮助,更体现出张玉顺教授团队锐意进取,开拓创新的科研精神。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1985573, encodeId=812819855e312, content=<a href='/topic/show?id=7f68904898a' target=_blank style='color:#2F92EE;'>#西安交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90489, encryptionId=7f68904898a, topicName=西安交大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Wed Jul 08 16:08:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29353, encodeId=6db0293531e, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:36:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455577, encodeId=a27514555e71e, content=<a href='/topic/show?id=d15a4808371' target=_blank style='color:#2F92EE;'>#左心耳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48083, encryptionId=d15a4808371, topicName=左心耳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=386b5684768, createdName=jxrzshh, createdTime=Wed Jun 17 00:08:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459420, encodeId=dfdd14594204b, content=<a href='/topic/show?id=0820542427d' target=_blank style='color:#2F92EE;'>#房间隔缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54242, encryptionId=0820542427d, topicName=房间隔缺损)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 17 00:08:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27678, encodeId=360d2e678ef, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Mon Jun 15 17:14:00 CST 2015, time=2015-06-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1985573, encodeId=812819855e312, content=<a href='/topic/show?id=7f68904898a' target=_blank style='color:#2F92EE;'>#西安交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90489, encryptionId=7f68904898a, topicName=西安交大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Wed Jul 08 16:08:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29353, encodeId=6db0293531e, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:36:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455577, encodeId=a27514555e71e, content=<a href='/topic/show?id=d15a4808371' target=_blank style='color:#2F92EE;'>#左心耳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48083, encryptionId=d15a4808371, topicName=左心耳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=386b5684768, createdName=jxrzshh, createdTime=Wed Jun 17 00:08:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459420, encodeId=dfdd14594204b, content=<a href='/topic/show?id=0820542427d' target=_blank style='color:#2F92EE;'>#房间隔缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54242, encryptionId=0820542427d, topicName=房间隔缺损)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 17 00:08:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27678, encodeId=360d2e678ef, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Mon Jun 15 17:14:00 CST 2015, time=2015-06-15, status=1, ipAttribution=)]
    2015-06-25 huaxipanxing

    看看

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1985573, encodeId=812819855e312, content=<a href='/topic/show?id=7f68904898a' target=_blank style='color:#2F92EE;'>#西安交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90489, encryptionId=7f68904898a, topicName=西安交大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Wed Jul 08 16:08:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29353, encodeId=6db0293531e, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:36:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455577, encodeId=a27514555e71e, content=<a href='/topic/show?id=d15a4808371' target=_blank style='color:#2F92EE;'>#左心耳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48083, encryptionId=d15a4808371, topicName=左心耳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=386b5684768, createdName=jxrzshh, createdTime=Wed Jun 17 00:08:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459420, encodeId=dfdd14594204b, content=<a href='/topic/show?id=0820542427d' target=_blank style='color:#2F92EE;'>#房间隔缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54242, encryptionId=0820542427d, topicName=房间隔缺损)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 17 00:08:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27678, encodeId=360d2e678ef, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Mon Jun 15 17:14:00 CST 2015, time=2015-06-15, status=1, ipAttribution=)]
    2015-06-17 jxrzshh
  4. [GetPortalCommentsPageByObjectIdResponse(id=1985573, encodeId=812819855e312, content=<a href='/topic/show?id=7f68904898a' target=_blank style='color:#2F92EE;'>#西安交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90489, encryptionId=7f68904898a, topicName=西安交大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Wed Jul 08 16:08:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29353, encodeId=6db0293531e, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:36:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455577, encodeId=a27514555e71e, content=<a href='/topic/show?id=d15a4808371' target=_blank style='color:#2F92EE;'>#左心耳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48083, encryptionId=d15a4808371, topicName=左心耳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=386b5684768, createdName=jxrzshh, createdTime=Wed Jun 17 00:08:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459420, encodeId=dfdd14594204b, content=<a href='/topic/show?id=0820542427d' target=_blank style='color:#2F92EE;'>#房间隔缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54242, encryptionId=0820542427d, topicName=房间隔缺损)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 17 00:08:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27678, encodeId=360d2e678ef, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Mon Jun 15 17:14:00 CST 2015, time=2015-06-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1985573, encodeId=812819855e312, content=<a href='/topic/show?id=7f68904898a' target=_blank style='color:#2F92EE;'>#西安交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90489, encryptionId=7f68904898a, topicName=西安交大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Wed Jul 08 16:08:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29353, encodeId=6db0293531e, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:36:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455577, encodeId=a27514555e71e, content=<a href='/topic/show?id=d15a4808371' target=_blank style='color:#2F92EE;'>#左心耳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48083, encryptionId=d15a4808371, topicName=左心耳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=386b5684768, createdName=jxrzshh, createdTime=Wed Jun 17 00:08:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459420, encodeId=dfdd14594204b, content=<a href='/topic/show?id=0820542427d' target=_blank style='color:#2F92EE;'>#房间隔缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54242, encryptionId=0820542427d, topicName=房间隔缺损)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 17 00:08:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27678, encodeId=360d2e678ef, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Mon Jun 15 17:14:00 CST 2015, time=2015-06-15, status=1, ipAttribution=)]
    2015-06-15 惜言

    好好学习

    0

相关资讯

江苏首例左心耳封堵术在中大医院成功实施

近日,东南大学附属中大医院心血管病研究所联合心血管内科、胸心外科、麻醉科、影像科等学科,在来自德国巴德贝尔心脏中心余江涛教授的指导下,由该院马根山教授与丁建东主任医师顺利实施了江苏省首例左心耳封堵术。 据介绍,接受该手术的患者今年59岁,男性,患有房颤,多次出现脑栓塞病史,术前食道超声、CT检查排除心房血栓,左心耳形态适合封堵。患者在全麻状态下施行手术,专家采用介入微创的方法,

山东大学齐鲁医院成功实施左心耳封堵术

     近日,山东大学齐鲁医院心内科为一名心房颤动患者成功实施左心耳封堵术。 患者74岁,女,体重90 kg,有高血压病史,持续房颤病史6年,曾辗转就诊于省内多家医院。1月26日来山东大学齐鲁医院就诊并住院,术前心脏超声示心房扩大、结构重构明显,经食道心脏超声排除左心耳血栓。脑卒中风险CHA2DS-VASc评分4分,其年卒中风险4.0%。患者口服抗凝药

OCC 2014:经食管超声心动图全程护航左心耳封堵术

房颤是临床常见的疾病,缺血性卒中是其常见的重要并发症,预防卒中是房颤治疗的主要目标之一,但由于房颤患者的不断增加和抗凝疗法禁忌症的增多,新技术经导管左心耳封堵术已经成为介入心脏病学的新领域,而经食管超声心动图(TEE)在经导管左心耳封堵术前筛选、术中监测和引导及术后评价方面起着很重要的作用。 TEE 术前评价 (1)多切面探查以确定左房、左心耳内无血栓存在。(2)评价左心耳的大小、形态、耳垂的

从Protect-AF研究看左心耳封堵术用于房颤患者血栓栓塞的未来

左心耳封堵术(Left Atrial Appendage ocllusion,LAAO)是近年来发展的通过微创导管术封堵左心耳、以达到预防心房颤动(房颤)患者血栓栓塞的新技术。Protect-AF研究是关于LAAO的第一个随机对照研究,和既往的研究有很大不同:首先是既往研究都是非对照研究,和该研究是对比LAAO和华法林治疗的随机对照研究;其次,既往的研究入选的是抗凝禁忌或者是抗凝风险高的患者,

沪实施首例3D打印引导下左心耳封堵术

日前,上海仁济医院心内科何奔教授带领团队成功实施上海首例3D引导下左心耳封堵手术。“3D打印的心耳模型让我们更好地摸清‘地形’,找到最佳位置,封堵血栓窝点,达到预防左心耳血栓脱落引起患者卒中或致残的目的。” 房颤,是最常见的持续性心律失常。随着人口老龄化,房颤的患者越来越多,据统计,65岁以上人口中,每10人就有一个房颤患者。房颤时,心房丧失收缩功能,血液容易淤积在从心房伸出的耳状小囊——“心耳

Baidu
map
Baidu
map
Baidu
map